{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:10Z","timestamp":1791919990058,"version":"4.3.4"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"23","funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, CAPES","doi-asserted-by":"publisher","award":["PVE 118\/2013"],"award-info":[{"award-number":["PVE 118\/2013"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, CAPES","doi-asserted-by":"publisher","award":["051\/2013"],"award-info":[{"award-number":["051\/2013"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,10,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cysteine proteases are essential hydrolytic enzymes present in the majority of\norganisms, including viruses and unicellular parasites. Despite the high sequence identity\ndisplayed among these proteins, specific structural features across different species grant\ndistinct functions to these biomolecules, frequently related to pathological conditions.\nConsequently, their relevance as promising targets for potential specific inhibitors has\nbeen highlighted and occasionally validated in recent decades. In this review, we discuss\nthe recent outcomes of structure-based campaigns aiming the discovery of new inhibitor\nprototypes against cruzain and falcipain, as alternative therapeutic tools for Chagas disease\nand malaria treatments, respectively. Computational and synthetic approaches have\nbeen combined on hit optimization strategies and are also discussed herein. These rationales\nare extended to additional tropical infectious and neglected pathologies, such as\nschistosomiasis, leishmaniasis and babesiosis, and also to Alzheimer\u2019s Disease, a widespread\nneurodegenerative disease poorly managed by currently available drugs and recently\nlinked to particular physiopathological roles of human cysteine proteases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867324666170810165302","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T02:14:55Z","timestamp":1502936095000},"page":"4435-4453","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Structure-based Approaches Targeting Parasite Cysteine Proteases"],"prefix":"10.2174","volume":"26","author":[{"given":"Rafael Pinto","family":"Vieira","sequence":"first","affiliation":[{"name":"Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Corr\u00eaa","family":"Santos","sequence":"additional","affiliation":[{"name":"Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Salgado","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biochi.2015.11.002","volume":"122","author":"Costa T.F.","year":"2016","unstructured":"Costa T.F.; Lima A.P.; Natural cysteine protease inhibitors in protozoa: Fifteen years of the chagasin family. Biochimie 2016,122,197-207","journal-title":"Biochimie"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.pathol.1.110304.100151","volume":"1","author":"McKerrow J.H.","year":"2006","unstructured":"McKerrow J.H.; Caffrey C.; Kelly B.; Loke P.; Sajid M.; Proteases in parasitic diseases. Annu Rev Pathol 2006,1,497-536","journal-title":"Annu Rev Pathol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/QCO.0b013e328315cca9","volume":"21","author":"McKerrow J.H.","year":"2008","unstructured":"McKerrow J.H.; Rosenthal P.J.; Swenerton R.; Doyle P.; Development of protease inhibitors for protozoan infections. Curr Opin Infect Dis 2008,21(6),668-672","journal-title":"Curr Opin Infect Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1172\/JCI115456","volume":"88","author":"Rosenthal P.J.","year":"1991","unstructured":"Rosenthal P.J.; Wollish W.S.; Palmer J.T.; Rasnick D.; Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest 1991,88(5),1467-1472","journal-title":"J Clin Invest"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI116262","volume":"91","author":"Rosenthal P.J.","year":"1993","unstructured":"Rosenthal P.J.; Lee G.K.; Smith R.E.; Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J Clin Invest 1993,91(3),1052-1056","journal-title":"J Clin Invest"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1128\/AAC.40.7.1600","volume":"40","author":"Rosenthal P.J.","year":"1996","unstructured":"Rosenthal P.J.; Olson J.E.; Lee G.K.; Palmer J.T.; Klaus J.L.; Rasnick D.; Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob Agents Chemother 1996,40(7),1600-1603","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.188.4.725","volume":"188","author":"Engel J.C.","year":"1998","unstructured":"Engel J.C.; Doyle P.S.; Hsieh I.; McKerrow J.H.; Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J Exp Med 1998,188(4),725-734","journal-title":"J Exp Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1021\/cr0101656","volume":"102","author":"Lecaille F.","year":"2002","unstructured":"Lecaille F.; Kaleta J.; Br\u00f6mme D.; Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 2002,102(12),4459-4488","journal-title":"Chem Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.2174\/0929867311320250009","volume":"20","author":"Lima A.P.","year":"2013","unstructured":"Lima A.P.; Reis F.C.; Costa T.F.; Cysteine peptidase inhibitors in trypanosomatid parasites. Curr Med Chem 2013,20(25),3152-3173","journal-title":"Curr Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1590\/S0074-02762007005000093","volume":"102","author":"Schmunis G.A.","year":"2007","unstructured":"Schmunis G.A.; Epidemiology of Chagas disease in non-endemic countries: The role of international migration. Mem Inst Oswaldo Cruz 2007,102(Suppl. 1),75-85","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.actatropica.2009.07.019","volume":"115","author":"Gascon J.","year":"2010","unstructured":"Gascon J.; Bern C.; Pinazo M.J.; Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010,115(1-2),22-27","journal-title":"Acta Trop"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001135","volume":"5","author":"Roca C.","year":"2011","unstructured":"Roca C.; Pinazo M.J.; L\u00f3pez-Chejade P.; Bay\u00f3 J.; Posada E.; L\u00f3pez-Solana J.; G\u00e1llego M.; Port\u00fas M.; Gasc\u00f3n J.; Chagas-Clot Research Group. Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain. PLoS Negl Trop Dis 2011,5(4)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=13","unstructured":"World Health Organization (WHO). Chagas disease (American trypanosomiasis).(Accessed\nSeptember 02, 2016)."},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/CMR.00005-11","volume":"24","author":"Bern C.","year":"2011","unstructured":"Bern C.; Kjos S.; Yabsley M.J.; Montgomery S.P.; \n                        Trypanosoma cruzi and Chagas disease in the United States. Clin Microbiol Rev 2011,24(4),655-681","journal-title":"Clin Microbiol Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.2807\/ese.16.38.19975-en","volume":"16","author":"Albajar-Vinas P.","year":"2011","unstructured":"Albajar-Vinas P.; Jannin J.; The hidden Chagas disease burden in Europe. Euro surveillance: European communicable disease bulletin 2011,16(38),19975","journal-title":"Euro surveillance: European communicable disease bulletin"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002818","volume":"8","author":"Garza M.","year":"2014","unstructured":"Garza M.; Feria Arroyo T.P.; Casillas E.A.; Sanchez-Cordero V.; Rivaldi C.L.; Sarkar S.; Projected future distributions of vectors of Trypanosoma cruzi in North America under climate change scenarios. PLoS Negl Trop Dis 2014,8(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0020-7519(00)00141-7","volume":"30","author":"Patz J.A.","year":"2000","unstructured":"Patz J.A.; Graczyk T.K.; Geller N.; Vittor A.Y.; Effects of environmental change on emerging parasitic diseases. Int J Parasitol 2000,30(12-13),1395-1405","journal-title":"Int J Parasitol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1890\/08-0079.1","volume":"90","author":"Lafferty K.D.","year":"2009","unstructured":"Lafferty K.D.; The ecology of climate change and infectious diseases. Ecology 2009,90(4),888-900","journal-title":"Ecology"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/bchm.1997.378.1.1","volume":"378","author":"Cazzulo J.J.","year":"1997","unstructured":"Cazzulo J.J.; Stoka V.; Turk V.; Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi. Biol Chem 1997,378(1),1-10","journal-title":"Biol Chem"},{"key":"ref=20","first-page":"121","author":"da Silva E.B.","year":"2016","unstructured":"da Silva E.B.; do Nascimento Pereira G.A.; Ferreira R.S.; Trypanosomal cysteine peptidases: Target validation and\ndrug design strategies. Comprehensive Analysis of Parasite\nBiology: From Metabolism to Drug Discovery 2016,121-145","journal-title":"Comprehensive Analysis of Parasite\nBiology: From Metabolism to Drug Discovery"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/jmbi.1994.0137","volume":"247","author":"McGrath M.E.","year":"1995","unstructured":"McGrath M.E.; Eakin A.E.; Engel J.C.; McKerrow J.H.; Craik C.S.; Fletterick R.J.; The crystal structure of cruzain: A therapeutic target for Chagas\u2019 disease. J Mol Biol 1995,247(2),251-259","journal-title":"J Mol Biol"},{"key":"ref=22","unstructured":"World Health Organization (WHO). Fact Sheet: World Malaria Report 2015(Accessed September 01,\n2016)."},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/978-1-4419-8414-2_3","volume":"712","author":"Rosenthal P.J.","year":"2011","unstructured":"Rosenthal P.J.; Falcipains and other cysteine proteases of malaria parasites. Adv Exp Med Biol 2011,712,30-48","journal-title":"Adv Exp Med Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0166-6851(94)00128-6","volume":"67","author":"Asawamahasakda W.","year":"1994","unstructured":"Asawamahasakda W.; Ittarat I.; Chang C.C.; McElroy P.; Meshnick S.R.; Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. Mol Biochem Parasitol 1994,67(2),183-191","journal-title":"Mol Biochem Parasitol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1182\/blood.V87.10.4448.bloodjournal87104448","volume":"87","author":"Gamboa de Dom\u00ednguez N.D.","year":"1996","unstructured":"Gamboa de Dom\u00ednguez N.D.; Rosenthal P.J.; Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood 1996,87(10),4448-4454","journal-title":"Blood"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1517\/13543776.2013.743992","volume":"23","author":"Mane U.R.","year":"2013","unstructured":"Mane U.R.; Gupta R.C.; Nadkarni S.S.; Giridhar R.R.; Naik P.P.; Yadav M.R.; Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review. Expert Opin Ther Pat 2013,23(2),165-187","journal-title":"Expert Opin Ther Pat"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"DiMasi J.A.","year":"2016","unstructured":"DiMasi J.A.; Grabowski H.G.; Hansen R.W.; Innovation in the pharmaceutical industry: New estimates of R","journal-title":"J Health Econ"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/AAC.47.1.154-160.2003","volume":"47","author":"Shenai B.R.","year":"2003","unstructured":"Shenai B.R.; Lee B.J.; Alvarez-Hernandez A.; Chong P.Y.; Emal C.D.; Neitz R.J.; Roush W.R.; Rosenthal P.J.; Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob Agents Chemother 2003,47(1),154-160","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1021\/jm101020z","volume":"53","author":"Ripphausen P.","year":"2010","unstructured":"Ripphausen P.; Nisius B.; Peltason L.; Bajorath J.; Quo vadis, virtual screening? A comprehensive survey of prospective applications. J Med Chem 2010,53(24),8461-8467","journal-title":"J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.bmcl.2014.01.074","volume":"24","author":"Wang L.","year":"2014","unstructured":"Wang L.; Zhang S.; Zhu J.; Zhu L.; Liu X.; Shan L.; Huang J.; Zhang W.; Li H.; Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening. Bioorg Med Chem Lett 2014,24(5),1261-1264","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.bmc.2015.02.062","volume":"23","author":"Chakka S.K.","year":"2015","unstructured":"Chakka S.K.; Kalamuddin M.; Sundararaman S.; Wei L.; Mundra S.; Mahesh R.; Malhotra P.; Mohmmed A.; Kotra L.P.; Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents. Bioorg Med Chem 2015,23(9),2221-2240","journal-title":"Bioorg Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/ci200029y","volume":"51","author":"Shah F.","year":"2011","unstructured":"Shah F.; Mukherjee P.; Gut J.; Legac J.; Rosenthal P.J.; Tekwani B.L.; Avery M.A.; Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. J Chem Inf Model 2011,51(4),852-864","journal-title":"J Chem Inf Model"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002370","volume":"7","author":"Wiggers H.J.","year":"2013","unstructured":"Wiggers H.J.; Rocha J.R.; Fernandes W.B.; Sesti-Costa R.; Carneiro Z.A.; Cheleski J.; da Silva A.B.; Juliano L.; Cezari M.H.; Silva J.S.; McKerrow J.H.; Montanari C.A.; Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay. PLoS Negl Trop Dis 2013,7(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10822-013-9685-z","volume":"27","author":"Mugumbate G.","year":"2013","unstructured":"Mugumbate G.; Newton A.S.; Rosenthal P.J.; Gut J.; Moreira R.; Chibale K.; Guedes R.C.; Novel anti-plasmodial hits identified by virtual screening of the ZINC database. J Comput Aided Mol Des 2013,27(10),859-871","journal-title":"J Comput Aided Mol Des"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1747-0285.2012.01416.x","volume":"80","author":"Rogers K.E.","year":"2012","unstructured":"Rogers K.E.; Ker\u00e4nen H.; Durrant J.D.; Ratnam J.; Doak A.; Arkin M.R.; McCammon J.A.; Novel cruzain inhibitors for the treatment of Chagas\u2019 disease. Chem Biol Drug Des 2012,80(3),398-405","journal-title":"Chem Biol Drug Des"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1021\/jm100488w","volume":"53","author":"Ferreira R.S.","year":"2010","unstructured":"Ferreira R.S.; Simeonov A.; Jadhav A.; Eidam O.; Mott B.T.; Keiser M.J.; McKerrow J.H.; Maloney D.J.; Irwin J.J.; Shoichet B.K.; Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem 2010,53(13),4891-4905","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/ci2005516","volume":"52","author":"Shah F.","year":"2012","unstructured":"Shah F.; Gut J.; Legac J.; Shivakumar D.; Sherman W.; Rosenthal P.J.; Avery M.A.; Computer-aided drug design of falcipain inhibitors: virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis. J Chem Inf Model 2012,52(3),696-710","journal-title":"J Chem Inf Model"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/jm401709b","volume":"57","author":"Ferreira R.S.","year":"2014","unstructured":"Ferreira R.S.; Dessoy M.A.; Pauli I.; Souza M.L.; Krogh R.; Sales A.I.; Oliva G.; Dias L.C.; Andricopulo A.D.; Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents. J Med Chem 2014,57(6),2380-2392","journal-title":"J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/07391102.2002.10506783","volume":"19","author":"Sabnis Y.","year":"2002","unstructured":"Sabnis Y.; Rosenthal P.J.; Desai P.; Avery M.A.; Homology modeling of falcipain-2: validation, de novo ligand design and synthesis of novel inhibitors. J Biomol Struct Dyn 2002,19(5),765-774","journal-title":"J Biomol Struct Dyn"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bmcl.2014.01.062","volume":"24","author":"Weldon D.J.","year":"2014","unstructured":"Weldon D.J.; Shah F.; Chittiboyina A.G.; Sheri A.; Chada R.R.; Gut J.; Rosenthal P.J.; Shivakumar D.; Sherman W.; Desai P.; Jung J.C.; Avery M.A.; Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of \u03b1-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum. Bioorg Med Chem Lett 2014,24(5),1274-1279","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"Friesner R.A.","year":"2004","unstructured":"Friesner R.A.; Banks J.L.; Murphy R.B.; Halgren T.A.; Klicic J.J.; Mainz D.T.; Repasky M.P.; Knoll E.H.; Shelley M.; Perry J.K.; Shaw D.E.; Francis P.; Shenkin P.S.; Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004,47(7),1739-1749","journal-title":"J Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"Friesner R.A.","year":"2006","unstructured":"Friesner R.A.; Murphy R.B.; Repasky M.P.; Frye L.L.; Greenwood J.R.; Halgren T.A.; Sanschagrin P.C.; Mainz D.T.; Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006,49(21),6177-6196","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/jm8013663","volume":"52","author":"Kerr I.D.","year":"2009","unstructured":"Kerr I.D.; Lee J.H.; Pandey K.C.; Harrison A.; Sajid M.; Rosenthal P.J.; Brinen L.S.; Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity. J Med Chem 2009,52(3),852-857","journal-title":"J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/bmj.296.6635.1486","volume":"296","author":"Bruce-Chwatt L.J.","year":"1988","unstructured":"Bruce-Chwatt L.J.; Three hundred and fifty years of the Peruvian fever bark. Br Med J (Clin Res Ed) 1988,296(6635),1486-1487","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.fitote.2014.01.017","volume":"94","author":"Jin H.","year":"2014","unstructured":"Jin H.; Xu Z.; Cui K.; Zhang T.; Lu W.; Huang J.; Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II. Fitoterapia 2014,94,55-61","journal-title":"Fitoterapia"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"14218","DOI":"10.1074\/jbc.274.20.14218","volume":"274","author":"Le Bonniec S.","year":"1999","unstructured":"Le Bonniec S.; Deregnaucourt C.; Redeker V.; Banerjee R.; Grellier P.; Goldberg D.E.; Schr\u00e9vel J.; Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem 1999,274(20),14218-14223","journal-title":"J Biol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1182\/blood-2002-01-0101","volume":"100","author":"Hanspal M.","year":"2002","unstructured":"Hanspal M.; Dua M.; Takakuwa Y.; Chishti A.H.; Mizuno A.; \n                        Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 2002,100(3),1048-1054","journal-title":"Blood"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"30180","DOI":"10.1074\/jbc.M305132200","volume":"278","author":"Dhawan S.","year":"2003","unstructured":"Dhawan S.; Dua M.; Chishti A.H.; Hanspal M.; Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J Biol Chem 2003,278(32),30180-30186","journal-title":"J Biol Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","volume":"284","author":"Kerr I.D.","year":"2009","unstructured":"Kerr I.D.; Lee J.H.; Farady C.J.; Marion R.; Rickert M.; Sajid M.; Pandey K.C.; Caffrey C.R.; Legac J.; Hansell E.; McKerrow J.H.; Craik C.S.; Rosenthal P.J.; Brinen L.S.; Vinyl sulfones as antiparasitic agents and a structural basis for drug design. J Biol Chem 2009,284(38),25697-25703","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000825","volume":"4","author":"Chen Y.T.","year":"2010","unstructured":"Chen Y.T.; Brinen L.S.; Kerr I.D.; Hansell E.; Doyle P.S.; McKerrow J.H.; Roush W.R.; \n                        In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi. PLoS Negl Trop Dis 2010,4(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1021\/acsmedchemlett.5b00336","volume":"7","author":"Jones B.D.","year":"2015","unstructured":"Jones B.D.; Tochowicz A.; Tang Y.; Cameron M.D.; McCall L.I.; Hirata K.; Siqueira-Neto J.L.; Reed S.L.; McKerrow J.H.; Roush W.R.; Synthesis and evaluation of oxyguanidine analogues of the cysteine protease inhibitor WRR-483 against Cruzain. ACS Med Chem Lett 2015,7(1),77-82","journal-title":"ACS Med Chem Lett"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/cmdc.201300202","volume":"8","author":"Oliveira R.","year":"2013","unstructured":"Oliveira R.; Newton A.S.; Guedes R.C.; Miranda D.; Amewu R.K.; Srivastava A.; Gut J.; Rosenthal P.J.; O\u2019Neill P.M.; Ward S.A.; Lopes F.; Moreira R.; An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites. ChemMedChem 2013,8(9),1528-1536","journal-title":"ChemMedChem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/jm5004528","volume":"57","author":"Oliveira R.","year":"2014","unstructured":"Oliveira R.; Guedes R.C.; Meireles P.; Albuquerque I.S.; Gon\u00e7alves L.M.; Pires E.; Bronze M.R.; Gut J.; Rosenthal P.J.; Prud\u00eancio M.; Moreira R.; O\u2019Neill P.M.; Lopes F.; Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials. J Med Chem 2014,57(11),4916-4923","journal-title":"J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1016\/j.bmcl.2009.04.100","volume":"19","author":"Capela R.","year":"2009","unstructured":"Capela R.; Oliveira R.; Gon\u00e7alves L.M.; Domingos A.; Gut J.; Rosenthal P.J.; Lopes F.; Moreira R.; Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition. Bioorg Med Chem Lett 2009,19(12),3229-3232","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1021\/jm030571c","volume":"47","author":"O\u2019Neill P.M.","year":"2004","unstructured":"O\u2019Neill P.M.; Posner G.H.; A medicinal chemistry perspective on artemisinin and related endoperoxides. J Med Chem 2004,47(12),2945-2964","journal-title":"J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"17579","DOI":"10.1073\/pnas.0804338105","volume":"105","author":"Cosl\u00e9dan F.","year":"2008","unstructured":"Cosl\u00e9dan F.; Fraisse L.; Pellet A.; Guillou F.; Mordm\u00fcller B.; Kremsner P.G.; Moreno A.; Mazier D.; Maffrand J.P.; Meunier B.; Selection of a trioxaquine as an antimalarial drug candidate. Proc Natl Acad Sci USA 2008,105(45),17579-17584","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1128\/AAC.05133-11","volume":"55","author":"Capela R.","year":"2011","unstructured":"Capela R.; Cabal G.G.; Rosenthal P.J.; Gut J.; Mota M.M.; Moreira R.; Lopes F.; Prud\u00eancio M.; Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy. Antimicrob Agents Chemother 2011,55(10),4698-4706","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1039\/c2md00277a","volume":"3","author":"Slack R.D.","year":"2012","unstructured":"Slack R.D.; Jacobine A.M.; Posner G.H.; Antimalarial peroxides: Advances in drug discovery and design. MedChemComm 2012,3(3),281-297","journal-title":"MedChemComm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1021\/jm0493111","volume":"47","author":"Altmann E.","year":"2004","unstructured":"Altmann E.; Cowan-Jacob S.W.; Missbach M.; Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K. J Med Chem 2004,47(24),5833-5836","journal-title":"J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1016\/j.bmcl.2003.08.006","volume":"13","author":"Greenspan P.D.","year":"2003","unstructured":"Greenspan P.D.; Clark K.L.; Cowen S.D.; McQuire L.W.; Tommasi R.A.; Farley D.L.; Quadros E.; Coppa D.E.; Du Z.; Fang Z.; Zhou H.; Doughty J.; Toscano K.T.; Wigg A.M.; Zhou S.; N-arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B. Bioorg Med Chem Lett 2003,13(22),4121-4124","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1021\/jm901069a","volume":"53","author":"Mott B.T.","year":"2010","unstructured":"Mott B.T.; Ferreira R.S.; Simeonov A.; Jadhav A.; Ang K.K.; Leister W.; Shen M.; Silveira J.T.; Doyle P.S.; Arkin M.R.; McKerrow J.H.; Inglese J.; Austin C.P.; Thomas C.J.; Shoichet B.K.; Maloney D.J.; Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB. J Med Chem 2010,53(1),52-60","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cmdc.201000449","volume":"6","author":"Ehmke V.","year":"2011","unstructured":"Ehmke V.; Heindl C.; Rottmann M.; Freymond C.; Schweizer W.B.; Brun R.; Stich A.; Schirmeister T.; Diederich F.; Potent and selective inhibition of cysteine proteases from Plasmodium falciparum and Trypanosoma brucei. ChemMedChem 2011,6(2),273-278","journal-title":"ChemMedChem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1039\/c2ob00034b","volume":"10","author":"Ehmke V.","year":"2012","unstructured":"Ehmke V.; Quinsaat J.E.; Rivera-Fuentes P.; Heindl C.; Freymond C.; Rottmann M.; Brun R.; Schirmeister T.; Diederich F.; Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors. Org Biomol Chem 2012,10(30),5764-5768","journal-title":"Org Biomol Chem"},{"key":"ref=64","unstructured":"World Health Organization (WHO). Schistosomiasis(Accessed September\n02, 2016)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"35770","DOI":"10.1074\/jbc.M111.271304","volume":"286","author":"J\u00edlkov\u00e1 A.","year":"2011","unstructured":"J\u00edlkov\u00e1 A.; Rez\u00e1cov\u00e1 P.; Leps\u00edk M.; Horn M.; V\u00e1chov\u00e1 J.; Fanfrl\u00edk J.; Brynda J.; McKerrow J.H.; Caffrey C.R.; Mares M.; Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni. J Biol Chem 2011,286(41),35770-35781","journal-title":"J Biol Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/AAC.04601-14","volume":"59","author":"Fonseca N.C.","year":"2015","unstructured":"Fonseca N.C.; da Cruz L.F.; da Silva Villela F.; do Nascimento Pereira G.A.; de Siqueira-Neto J.L.; Kellar D.; Suzuki B.M.; Ray D.; de Souza T.B.; Alves R.J.; Sales J\u00fanior P.A.; Romanha A.J.; Murta S.M.; McKerrow J.H.; Caffrey C.R.; de Oliveira R.B.; Ferreira R.S.; Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1. Antimicrob Agents Chemother 2015,59(5),2666-2677","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0968-0896(99)00004-8","volume":"7","author":"Olson J.E.","year":"1999","unstructured":"Olson J.E.; Lee G.K.; Semenov A.; Rosenthal P.J.; Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. Bioorg Med Chem 1999,7(4),633-638","journal-title":"Bioorg Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1021\/jp409604n","volume":"117","author":"Fanfrl\u00edk J.","year":"2013","unstructured":"Fanfrl\u00edk J.; Brahmkshatriya P.S.; \u0158ez\u00e1\u010d J.; J\u00edlkov\u00e1 A.; Horn M.; Mare\u0161 M.; Hobza P.; Lep\u0161\u00edk M.; Quantum mechanics-based scoring rationalizes the irreversible inactivation of parasitic Schistosoma mansoni cysteine peptidase by vinyl sulfone inhibitors. J Phys Chem B 2013,117(48),14973-14982","journal-title":"J Phys Chem B"},{"key":"ref=69","unstructured":"World Health Organization (WHO). Leishmaniasis.(Accessed September\n02, 2016)"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077460","volume":"8","author":"Schr\u00f6der J.","year":"2013","unstructured":"Schr\u00f6der J.; Noack S.; Marh\u00f6fer R.J.; Mottram J.C.; Coombs G.H.; Selzer P.M.; Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB. PLoS One 2013,8(10)","journal-title":"PLoS One"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/jm010459j","volume":"45","author":"Du X.","year":"2002","unstructured":"Du X.; Guo C.; Hansell E.; Doyle P.S.; Caffrey C.R.; Holler T.P.; McKerrow J.H.; Cohen F.E.; Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem 2002,45(13),2695-2707","journal-title":"J Med Chem"},{"key":"ref=72","first-page":"1","author":"Vital D.G.","year":"2016","unstructured":"Vital D.G.; Damasceno F.S.; Rapado L.N.; Silber A.M.; Vilella F.S.; Ferreira R.S.; Maltarollo V.G.; Trossini G.H.; Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: A theoretical and experimental study. J Biomol Struct Dyn 2016,1-16","journal-title":"J Biomol Struct Dyn"},{"key":"ref=73","unstructured":"Centers for Disease Control and Prevention (CDC). Parasites - Babesiosis(Accessed\nSeptember 04, 2016)."},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.vetpar.2006.01.042","volume":"138","author":"de Waal D.T.","year":"2006","unstructured":"de Waal D.T.; Combrink M.P.; Live vaccines against bovine babesiosis. Vet Parasitol 2006,138(1-2),88-96","journal-title":"Vet Parasitol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"G29","DOI":"10.1016\/j.vaccine.2008.09.070","volume":"26","author":"Fish L.","year":"2008","unstructured":"Fish L.; Leibovich B.; Krigel Y.; McElwain T.; Shkap V.; Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens. Vaccine 2008,26(Suppl. 6),G29-G33","journal-title":"Vaccine"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.meegid.2012.07.004","volume":"12","author":"Schnittger L.","year":"2012","unstructured":"Schnittger L.; Rodriguez A.E.; Florin-Christensen M.; Morrison D.A.; Babesia: a world emerging. Infect Genet Evol 2012,12(8),1788-1809","journal-title":"Infect Genet Evol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.exppara.2007.04.009","volume":"117","author":"Okubo K.","year":"2007","unstructured":"Okubo K.; Yokoyama N.; Govind Y.; Alhassan A.; Igarashi I.; \n                        Babesia bovis: Effects of cysteine protease inhibitors on in vitro growth. Exp Parasitol 2007,117(2),214-217","journal-title":"Exp Parasitol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.exppara.2010.07.012","volume":"127","author":"Martins T.M.","year":"2011","unstructured":"Martins T.M.; do Ros\u00e1rio V.E.; Domingos A.; Identification of papain-like cysteine proteases from the bovine piroplasm Babesia bigemina and evolutionary relationship of piroplasms C1 family of cysteine proteases. Exp Parasitol 2011,127(1),184-194","journal-title":"Exp Parasitol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10822-013-9682-2","volume":"27","author":"P\u00e9rez B.","year":"2013","unstructured":"P\u00e9rez B.; Antunes S.; Gon\u00e7alves L.M.; Domingos A.; Gomes J.R.; Gomes P.; Teixeira C.; Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: In vitro evaluation, homology modeling and molecular docking studies. J Comput Aided Mol Des 2013,27(9),823-835","journal-title":"J Comput Aided Mol Des"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ejmech.2012.05.022","volume":"54","author":"P\u00e9rez B.C.","year":"2012","unstructured":"P\u00e9rez B.C.; Teixeira C.; Figueiras M.; Gut J.; Rosenthal P.J.; Gomes J.R.; Gomes P.; Novel cinnamic acid\/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: towards the development of potential dual action antimalarials. Eur J Med Chem 2012,54,887-899","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1128\/AAC.00734-13","volume":"57","author":"Ndao M.","year":"2013","unstructured":"Ndao M.; Nath-Chowdhury M.; Sajid M.; Marcus V.; Mashiyama S.T.; Sakanari J.; Chow E.; Mackey Z.; Land K.M.; Jacobson M.P.; Kalyanaraman C.; McKerrow J.H.; Arrowood M.J.; Caffrey C.R.; A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection. Antimicrob Agents Chemother 2013,57(12),6063-6073","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1021\/jm4006719","volume":"56","author":"Schiefer I.T.","year":"2013","unstructured":"Schiefer I.T.; Tapadar S.; Litosh V.; Siklos M.; Scism R.; Wijewickrama G.T.; Chandrasena E.P.; Sinha V.; Tavassoli E.; Brunsteiner M.; Fa\u2019 M.; Arancio O.; Petukhov P.; Thatcher G.R.; Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors. J Med Chem 2013,56(15),6054-6068","journal-title":"J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.1021\/acs.jmedchem.5b00746","volume":"58","author":"Bori\u0161ek J.","year":"2015","unstructured":"Bori\u0161ek J.; Vizovi\u0161ek M.; Sosnowski P.; Turk B.; Turk D.; Mohar B.; Novi\u010d M.; Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. J Med Chem 2015,58(17),6928-6937","journal-title":"J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.bmcl.2014.12.057","volume":"25","author":"Grosche P.","year":"2015","unstructured":"Grosche P.; Sirockin F.; Mac Sweeney A.; Ramage P.; Erbel P.; Melkko S.; Bernardi A.; Hughes N.; Ellis D.; Combrink K.D.; Jarousse N.; Altmann E.; Structure-based design and optimization of potent inhibitors of the adenoviral protease. Bioorg Med Chem Lett 2015,25(3),438-443","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1021\/acs.jmedchem.5b01013","volume":"58","author":"Zhai Y.","year":"2015","unstructured":"Zhai Y.; Zhao X.; Cui Z.; Wang M.; Wang Y.; Li L.; Sun Q.; Yang X.; Zeng D.; Liu Y.; Sun Y.; Lou Z.; Shang L.; Yin Z.; Cyanohydrin as an anchoring group for potent and selective inhibitors of enterovirus 71 3C protease. J Med Chem 2015,58(23),9414-9420","journal-title":"J Med Chem"},{"key":"ref=86","unstructured":"World Health Organization (WHO). Fact sheet: Dementia.(Accessed\nSeptember 02, 2016)"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011585","volume":"2","author":"Holtzman D.M.","year":"2012","unstructured":"Holtzman D.M.; Mandelkow E.; Selkoe D.J.; Alzheimer disease in 2020. Cold Spring Harb Perspect Med 2012,2(11)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/197192b0","volume":"197","author":"Kidd M.","year":"1963","unstructured":"Kidd M.; Paired helical filaments in electron microscopy of Alzheimer\u2019s disease. Nature 1963,197,192-193","journal-title":"Nature"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"Blennow K.","year":"2006","unstructured":"Blennow K.; de Leon M.J.; Zetterberg H.; Alzheimer\u2019s disease. Lancet 2006,368(9533),387-403","journal-title":"Lancet"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.3233\/JAD-2012-129039","volume":"33","author":"Klein W.L.","year":"2013","unstructured":"Klein W.L.; Synaptotoxic amyloid-\u03b2 oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer\u2019s disease? J Alzheimers Dis 2013,33(Suppl. 1),S49-S65","journal-title":"J Alzheimers Dis"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"Selkoe D.J.","year":"2016","unstructured":"Selkoe D.J.; Hardy J.; The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 2016,8(6),595-608","journal-title":"EMBO Mol Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1471-4159.2002.00794.x","volume":"81","author":"Hook V.Y.","year":"2002","unstructured":"Hook V.Y.; Toneff T.; Aaron W.; Yasothornsrikul S.; Bundey R.; Reisine T.; Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles. J Neurochem 2002,81(2),237-256","journal-title":"J Neurochem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1515\/BC.2005.108","volume":"386","author":"Hook V.","year":"2005","unstructured":"Hook V.; Toneff T.; Bogyo M.; Greenbaum D.; Medzihradszky K.F.; Neveu J.; Lane W.; Hook G.; Reisine T.; Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer\u2019s disease. Biol Chem 2005,386(9),931-940","journal-title":"Biol Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1515\/BC.2007.117","volume":"388","author":"Hook G.","year":"2007","unstructured":"Hook G.; Hook V.Y.; Kindy M.; Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer\u2019s disease therapeutics. Biol Chem 2007,388(9),979-983","journal-title":"Biol Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/bc.2010.110","volume":"391","author":"Hook V.","year":"2010","unstructured":"Hook V.; Hook G.; Kindy M.; Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer\u2019s disease. Biol Chem 2010,391(8),861-872","journal-title":"Biol Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1074\/jbc.M708362200","volume":"283","author":"Hook V.Y.","year":"2008","unstructured":"Hook V.Y.; Kindy M.; Hook G.; Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem 2008,283(12),7745-7753","journal-title":"J Biol Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/JAD-2011-110101","volume":"26","author":"Hook G.","year":"2011","unstructured":"Hook G.; Hook V.; Kindy M.; The cysteine protease inhibitor, E64d, reduces brain amyloid-\u03b2 and improves memory deficits in Alzheimer\u2019s disease animal models by inhibiting cathepsin B, but not BACE1, \u03b2-secretase activity. J Alzheimers Dis 2011,26(2),387-408","journal-title":"J Alzheimers Dis"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fneur.2015.00178","volume":"6","author":"Hook G.","year":"2015","unstructured":"Hook G.; Jacobsen J.S.; Grabstein K.; Kindy M.; Hook V.; Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate. Front Neurol 2015,6,178","journal-title":"Front Neurol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1210\/en.2008-1613","volume":"150","author":"Biswas N.","year":"2009","unstructured":"Biswas N.; Rodriguez-Flores J.L.; Courel M.; Gayen J.R.; Vaingankar S.M.; Mahata M.; Torpey J.W.; Taupenot L.; O\u2019Connor D.T.; Mahata S.K.; Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides. Endocrinology 2009,150(8),3547-3557","journal-title":"Endocrinology"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.npep.2010.08.003","volume":"44","author":"Funkelstein L.","year":"2010","unstructured":"Funkelstein L.; Beinfeld M.; Minokadeh A.; Zadina J.; Hook V.; Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides. Neuropeptides 2010,44(6),457-466","journal-title":"Neuropeptides"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbapap.2011.08.015","volume":"1824","author":"Hook V.","year":"2012","unstructured":"Hook V.; Funkelstein L.; Wegrzyn J.; Bark S.; Kindy M.; Hook G.; Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer\u2019s disease. Biochim Biophys Acta 2012,1824(1),89-104","journal-title":"Biochim Biophys Acta"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/154875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T08:51:01Z","timestamp":1573116661000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/154875\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":101,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,10,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867324666170810165302","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}